22nd week of 2020 patent applcation highlights part 21 |
Patent application number | Title | Published |
20200165273 | FLUORINATED ETHER COMPOUND, FLUORINATED ETHER COMPOSITION, COATING LIQUID, ARTICLE AND ITS PRODUCTION METHOD | 2020-05-28 |
20200165274 | NOVEL ISOCYANIDE COMPOUND AND HYDROSILYLATION REACTION CATALYST | 2020-05-28 |
20200165275 | COMPOUND HAVING ALKOXYSILYL GROUP AND ACTIVE ESTER GROUP, METHOD FOR PREPARING SAME, COMPOSITION COMPRISING SAME, AND USE | 2020-05-28 |
20200165276 | NITROGEN-CONTAINING CYCLIC ORGANOXYSILANE COMPOUND AND METHOD FOR PRODUCING THE SAME | 2020-05-28 |
20200165277 | ISOCYANURIC ACID DERIVATIVE HAVING ALKOXYALKYL GROUPS AND METHOD FOR PRODUCING THE SAME | 2020-05-28 |
20200165278 | NOVEL HALOGERMANIDES AND METHODS FOR THE PREPARATION THEREOF | 2020-05-28 |
20200165279 | PHENYL-HETEROCYCLE-PHENYL DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA | 2020-05-28 |
20200165280 | MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | 2020-05-28 |
20200165281 | BODIPY COMPOUNDS FOR USE IN DISPLAY DEVICES | 2020-05-28 |
20200165282 | TRIDENTATE IMINOPYRROLYL NICKEL COMPLEXES AND THEIR USE AS CATALYSTS FOR THE REACTION OF POLYMERISATION OF ETHYLENE TO HYPERBRANCHED POLYETHYLENE | 2020-05-28 |
20200165283 | PROCESS | 2020-05-28 |
20200165284 | METHOD FOR PREPARING CANAGLIFLOZIN AMORPHOUS FORM | 2020-05-28 |
20200165285 | PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE AS TRANSGLUCOSYLASE ACCEPTOR SUBSTRATES IN THE CHEMO-ENZYMATIC SYNTHESIS OF SHIGELLA FLEXNERI SPECIFIC OLIGOSACCHARIDES | 2020-05-28 |
20200165286 | TUNICAMYCIN ANALOGUES | 2020-05-28 |
20200165287 | SALT OF (SS)-ADENOSYL METHIONINE WITH INOSITOL HEXAPHOSPHATE, AND PROCESS FOR THE PREPARATION THEREOF | 2020-05-28 |
20200165288 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | 2020-05-28 |
20200165289 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF OBETICHOLIC ACID AND DERIVATIVES THEREOF | 2020-05-28 |
20200165290 | ISOTOPICALLY LABELED BILE ACID DERIVATIVES | 2020-05-28 |
20200165291 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | 2020-05-28 |
20200165292 | SYNTHESIS OF URSOLIC ACID NANOPARTICLES | 2020-05-28 |
20200165293 | SYNTHESIS OF URSOLIC ACID NANOPARTICLES | 2020-05-28 |
20200165294 | SYNTHESIS OF URSOLIC ACID NANOPARTICLES | 2020-05-28 |
20200165295 | METHOD FOR PURIFYING ANTI-IL-6 RECEPTOR ANTIBODIES | 2020-05-28 |
20200165296 | METHOD FOR IN VITRO GLYCOENGINEERING OF ANTIBODIES | 2020-05-28 |
20200165297 | OPTIMIZED METHOD FOR ANTIBODY CAPTURING BY MIXED MODE CHROMATOGRAPHY | 2020-05-28 |
20200165298 | INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES | 2020-05-28 |
20200165299 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION | 2020-05-28 |
20200165300 | Cyclic Peptides Targeting Alpha-4-Beta-7 Integrin | 2020-05-28 |
20200165301 | ARTIFICIAL PROTEINS AND COMPOSITIONS AND METHODS THEREOF | 2020-05-28 |
20200165302 | MODIFIED VSV-G AND VACCINES THEREOF | 2020-05-28 |
20200165303 | Compositions and Methods Related to HIV-1 Immunogens | 2020-05-28 |
20200165304 | METHOD FOR MODIFYING RNA BINDING PROTEIN USING PPR MOTIF | 2020-05-28 |
20200165305 | USE OF CGRP RECEPTOR ANTAGONISTS IN NEUROPROTECTION AND NEUROLOGICAL DISORDERS | 2020-05-28 |
20200165306 | Optically Transparent Silk Hydrogels | 2020-05-28 |
20200165307 | METHODS AND REAGENTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION | 2020-05-28 |
20200165308 | NETRIN- 1 AND DEPENDENCE RECEPTOR PROTEINS AND METHOD OF USE | 2020-05-28 |
20200165309 | ANTIMICROBIAL PEPTIDES WITH ALPHA-CORE HELICES | 2020-05-28 |
20200165310 | Colon and Pancreas Cancer Peptidomimetics | 2020-05-28 |
20200165311 | Polypeptide Solution, Production Method for Polypeptide Fiber, and Artificial Polypeptide | 2020-05-28 |
20200165312 | COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE | 2020-05-28 |
20200165313 | EGF(A) ANALOGUES, PREPARATION, FORMULATIONS AND USES THEREOF | 2020-05-28 |
20200165314 | Compositions and Methods of Use for Treating Metabolic Disorders | 2020-05-28 |
20200165315 | INSULIN-TRANSFERRIN FUSION PROTEIN AND ITS PRODRUG, PROINSULIN-TRANSFERRIN, FOR OVERCOMING INSULIN RESISTANCE | 2020-05-28 |
20200165316 | HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF | 2020-05-28 |
20200165317 | METHODS AND COMPOSITIONS FOR PROTECTION AGAINST LENTIVIRAL INFECTIONS | 2020-05-28 |
20200165318 | COMPOSITIONS COMPRISING D-AMINO ACID PEPTIDES AND METHODS OF PRODUCTION AND USE THEREOF FOR INHIBITING AUTOANTIBODIES | 2020-05-28 |
20200165319 | POLYPEPTIDE, PROCESS FOR THE PRODUCTION THEREOF AND USE THEREOF | 2020-05-28 |
20200165320 | IN VITRO GLYCOENGINEERING OF ANTIBODIES | 2020-05-28 |
20200165321 | RE-USE OF ENZYMES IN IN VITRO GLYCOENGINEERING OF ANTIBODIES | 2020-05-28 |
20200165322 | IMMUNOGLOBULIN FRAMEWORKS WHICH DEMONSTRATE ENHANCED STABILITY IN THE INTRACELLULAR ENVIRONMENT AND METHODS OF IDENTIFYING SAME | 2020-05-28 |
20200165323 | ANTIBODY CAPABLE OF BINDING TO INFLUENZA VIRUS INTRANUCLEAR PROTEIN, COMPLEX, DETECTION APPARATUS AND DETECTION METHOD USING SAME | 2020-05-28 |
20200165324 | RAPID ELICITATION OF BROADLY NEUTRALIZING ANTIBODIES TO HIV ENV | 2020-05-28 |
20200165325 | HIGHLY ACTIVE AGONISTIC CD4 BINDING SITE ANTI-HIV ANTIBODIES (HAADS) COMPRISING MODIFIED CDRH2 REGIONS THAT IMPROVE CONTACT WITH GP120 | 2020-05-28 |
20200165326 | IMMUNOCONJUGATES WITH OPTIMIZED LINKERS AND ORIENTATION | 2020-05-28 |
20200165327 | EPITOPES IN THE RNA RECOGNITION MOTIF 1 (RRM1) OF TDP-43 AND MISFOLDING-SELECTIVE ANTIBODIES THERETO | 2020-05-28 |
20200165328 | Antibodies to Pyroglutamate Amyloid-B and Uses Thereof | 2020-05-28 |
20200165329 | CAMELID SINGLE-DOMAIN ANTIBODY DIRECTED AGAINST PHOSPHORYLATED TAU PROTEINS AND METHODS FOR PRODUCING CONJUGATES THEREOF | 2020-05-28 |
20200165330 | HIGH-AFFINITY ANTI-VEGF ANTIBODY | 2020-05-28 |
20200165331 | VNAR HAVING ANTI-ANGIOGENIC ACTIVITY IN SOLID TUMOURS OF PET ANIMALS | 2020-05-28 |
20200165332 | IPTG-FREE INDUCTION PROCESS FOR EXPRESSION OF BIOSIMILAR RHU RANIBIZUMAB ANTIBODY FRAGMENT USING E. COLI | 2020-05-28 |
20200165333 | FULLY HUMANIZED ANTI-PLATELET FACTOR 4 ANTIBODIES THAT TREAT HEPARIN-INDUCED THROMBOCYTOPENIA | 2020-05-28 |
20200165334 | INHIBITORS OF IL-38 FOR USE IN TREATING AND/OR PREVENTING CANCER IN A SUBJECT | 2020-05-28 |
20200165335 | HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER | 2020-05-28 |
20200165336 | MCAM ANTAGONISTS AND METHODS OF TREATMENT | 2020-05-28 |
20200165337 | HUMANIZED ANTIBODIES AGAINST C-KIT | 2020-05-28 |
20200165338 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | 2020-05-28 |
20200165339 | METHODS OF CD40 ACTIVATION AND IMMUNE CHECKPOINT BLOCKADE | 2020-05-28 |
20200165340 | ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODIES AND THERAPEUTIC USES THEREOF | 2020-05-28 |
20200165341 | Bispecific Antibodies for Activation of Immune Cells | 2020-05-28 |
20200165342 | HLA-DR CAR-T COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | 2020-05-28 |
20200165343 | COMPOSITIONS AND METHODS FOR INHIBITION OF MICA/B SHEDDING | 2020-05-28 |
20200165344 | PROTEINS BINDING NKG2D, CD16 AND FLT3 | 2020-05-28 |
20200165345 | BINDING AGONIST FOR TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS | 2020-05-28 |
20200165346 | CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS | 2020-05-28 |
20200165347 | METHOD OF TREATMENT USING IL-13R ANTIBODY | 2020-05-28 |
20200165348 | CD123-BINDING CHIMERIC ANTIGEN RECEPTORS | 2020-05-28 |
20200165349 | BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF | 2020-05-28 |
20200165350 | STRONG POTENTIATION OF IMMUNE CHECKPOINT BLOCKADE THERAPY OF CANCER BY COMBINATION WITH ENDOGLIN-TARGETING THERAPY | 2020-05-28 |
20200165351 | HUMANIZED ANTI-N-CADHERIN ANTIBODIES AND USES THEREOF | 2020-05-28 |
20200165352 | VARIANTS OF CD38 ANTIBODY AND USES THEREOF | 2020-05-28 |
20200165353 | ANTI-CD22 ANTIGEN BINDING MOLECULES TO TREAT LUNG CANCER AND PROSTATE CANCER | 2020-05-28 |
20200165354 | Novel Anti-PCSK9 Antibodies | 2020-05-28 |
20200165355 | ANTIBODIES TO UBIQUITIN C-TERMINAL HYDROLASE L1 (UCH-L1) AND GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND RELATED METHODS | 2020-05-28 |
20200165356 | HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN | 2020-05-28 |
20200165357 | CARBONIC ANHYDRASE IX (G250) ANTIBODIES AND METHODS OF USE THEREOF | 2020-05-28 |
20200165358 | METHODS AND COMPOSITIONS FOR EVALUATION AND TREATMENT OF SYNUCLEINOPATHIES | 2020-05-28 |
20200165359 | OXIDATION OF STARCH | 2020-05-28 |
20200165360 | DEXTRAN-POLY ALPHA-1,3-GLUCAN GRAFT COPOLYMERS AND SYNTHESIS METHODS THEREOF | 2020-05-28 |
20200165361 | Polyethylene Composition | 2020-05-28 |
20200165362 | POLYALPHAOLEFIN HAVING UNIFORM STRUCTURE AND METHOD OF PREPARING SAME | 2020-05-28 |
20200165363 | PHOTOPOLYMERIZABLE DENTAL COMPOSITES WITH RAPID CURING AND LOW SHRINKAGE STRESS | 2020-05-28 |
20200165364 | POLY(METH)ACRYLATE, AND COATING COMPOSITION AND COATED ARTICLE CONTAINING SAME | 2020-05-28 |
20200165365 | Plastics-Based Manufactured Article and Processes for Forming Said Article | 2020-05-28 |
20200165366 | Films Made from Polyethylene Compositions and Processes for Making Same | 2020-05-28 |
20200165367 | AQUEOUS POLYMER COMPOSITION AND COPOLYMER | 2020-05-28 |
20200165368 | POLYMER WITH BRANCHED STRUCTURE | 2020-05-28 |
20200165369 | ANTIFOULING FILM AND POLYMERIZABLE COMPOSITION | 2020-05-28 |
20200165370 | RUBBERY POLYMER, GRAFT COPOLYMER, AND THERMOPLASTIC RESIN COMPOSITION | 2020-05-28 |
20200165371 | FUNCTIONALIZED BLOCK COMPOSITE AND CRYSTALLINE BLOCK COMPOSITE COMPOSITIONS | 2020-05-28 |
20200165372 | BROMINATED FLAME RETARDANT | 2020-05-28 |